

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of p38MAPK cascade (GO:1900745) | 5.04323467 |
| 2 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.39236921 |
| 3 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.34126103 |
| 4 | central nervous system myelination (GO:0022010) | 4.30993262 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 4.30993262 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.29640210 |
| 7 | pentose-phosphate shunt (GO:0006098) | 4.27568447 |
| 8 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.27004870 |
| 9 | surfactant homeostasis (GO:0043129) | 4.17674755 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.08222095 |
| 11 | acyl-CoA biosynthetic process (GO:0071616) | 3.95639343 |
| 12 | thioester biosynthetic process (GO:0035384) | 3.95639343 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91745822 |
| 14 | response to peptidoglycan (GO:0032494) | 3.82101188 |
| 15 | fatty acid elongation (GO:0030497) | 3.81278590 |
| 16 | NADPH regeneration (GO:0006740) | 3.78972949 |
| 17 | activation of MAPKKK activity (GO:0000185) | 3.75437382 |
| 18 | valine metabolic process (GO:0006573) | 3.70992655 |
| 19 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.60966960 |
| 20 | regulation of p38MAPK cascade (GO:1900744) | 3.60728269 |
| 21 | creatine metabolic process (GO:0006600) | 3.59930152 |
| 22 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.58878386 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56219031 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.56219031 |
| 25 | protein localization to endosome (GO:0036010) | 3.50438256 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.48681759 |
| 27 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.47970573 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44929232 |
| 29 | positive regulation of histone deacetylation (GO:0031065) | 3.43140694 |
| 30 | lung epithelium development (GO:0060428) | 3.41158729 |
| 31 | polarized epithelial cell differentiation (GO:0030859) | 3.40120626 |
| 32 | axon ensheathment (GO:0008366) | 3.38462913 |
| 33 | ensheathment of neurons (GO:0007272) | 3.38462913 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36117597 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.36117597 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36117597 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36117597 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36117597 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 3.36117597 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.31961197 |
| 41 | regulation of mitotic spindle organization (GO:0060236) | 3.29009614 |
| 42 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.28981636 |
| 43 | myelination (GO:0042552) | 3.28318845 |
| 44 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.26641130 |
| 45 | low-density lipoprotein particle clearance (GO:0034383) | 3.23911668 |
| 46 | triglyceride biosynthetic process (GO:0019432) | 3.23789884 |
| 47 | collecting duct development (GO:0072044) | 3.23410981 |
| 48 | mature B cell differentiation involved in immune response (GO:0002313) | 3.22280646 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.21830801 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 3.21830801 |
| 51 | detection of other organism (GO:0098543) | 3.20186723 |
| 52 | pattern specification involved in kidney development (GO:0061004) | 3.18031964 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.17989933 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.17989933 |
| 55 | acylglycerol biosynthetic process (GO:0046463) | 3.15202025 |
| 56 | neutral lipid biosynthetic process (GO:0046460) | 3.15202025 |
| 57 | cortical actin cytoskeleton organization (GO:0030866) | 3.14553358 |
| 58 | myelin maintenance (GO:0043217) | 3.13097140 |
| 59 | acetyl-CoA metabolic process (GO:0006084) | 3.12751985 |
| 60 | response to type I interferon (GO:0034340) | 3.11443931 |
| 61 | barbed-end actin filament capping (GO:0051016) | 3.11235497 |
| 62 | histone H3-K36 demethylation (GO:0070544) | 3.10354263 |
| 63 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.08214395 |
| 64 | triglyceride catabolic process (GO:0019433) | 3.03248171 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.02847333 |
| 66 | maternal placenta development (GO:0001893) | 3.00481390 |
| 67 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.99976751 |
| 68 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.97464778 |
| 69 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97156760 |
| 70 | virion attachment to host cell (GO:0019062) | 2.96282310 |
| 71 | adhesion of symbiont to host cell (GO:0044650) | 2.96282310 |
| 72 | detection of bacterium (GO:0016045) | 2.95418619 |
| 73 | nucleoside transmembrane transport (GO:1901642) | 2.95062108 |
| 74 | stress fiber assembly (GO:0043149) | 2.94226700 |
| 75 | regulation of monocyte differentiation (GO:0045655) | 2.94089293 |
| 76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92413987 |
| 77 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.92156249 |
| 78 | biotin metabolic process (GO:0006768) | 2.91617054 |
| 79 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91421324 |
| 80 | L-phenylalanine catabolic process (GO:0006559) | 2.90710025 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.90710025 |
| 82 | hypotonic response (GO:0006971) | 2.90085380 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 2.89864885 |
| 84 | detection of molecule of bacterial origin (GO:0032490) | 2.88923077 |
| 85 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.87626630 |
| 86 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.87167916 |
| 87 | acylglycerol catabolic process (GO:0046464) | 2.87022044 |
| 88 | neutral lipid catabolic process (GO:0046461) | 2.87022044 |
| 89 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.85347238 |
| 90 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84725950 |
| 91 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.83710208 |
| 92 | cellular extravasation (GO:0045123) | 2.83565944 |
| 93 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.79902576 |
| 94 | germinal center formation (GO:0002467) | 2.79859511 |
| 95 | regulation of triglyceride metabolic process (GO:0090207) | 2.79643368 |
| 96 | plasma lipoprotein particle clearance (GO:0034381) | 2.79385214 |
| 97 | detection of external biotic stimulus (GO:0098581) | 2.77327075 |
| 98 | endocardial cushion development (GO:0003197) | 2.77249877 |
| 99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.76762844 |
| 100 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.76506807 |
| 101 | establishment of apical/basal cell polarity (GO:0035089) | 2.76307983 |
| 102 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75140348 |
| 103 | adhesion of symbiont to host (GO:0044406) | 2.74771742 |
| 104 | chemical homeostasis within a tissue (GO:0048875) | 2.73305401 |
| 105 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.73295268 |
| 106 | mannose metabolic process (GO:0006013) | 2.72761530 |
| 107 | sulfur amino acid catabolic process (GO:0000098) | 2.71050319 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70468361 |
| 109 | fatty acid transmembrane transport (GO:1902001) | 2.69696055 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.68868683 |
| 111 | regulation of triglyceride catabolic process (GO:0010896) | 2.68580898 |
| 112 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.67846193 |
| 113 | modulation by symbiont of host cellular process (GO:0044068) | 2.67678381 |
| 114 | angiogenesis involved in wound healing (GO:0060055) | 2.67221949 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.67136921 |
| 116 | regulation of tolerance induction (GO:0002643) | 2.66785908 |
| 117 | negative regulation of type 2 immune response (GO:0002829) | 2.65912258 |
| 118 | tolerance induction (GO:0002507) | 2.63785661 |
| 119 | basement membrane organization (GO:0071711) | 2.63567937 |
| 120 | pinocytosis (GO:0006907) | 2.62682099 |
| 121 | triglyceride metabolic process (GO:0006641) | 2.62250945 |
| 122 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.61907550 |
| 123 | detection of biotic stimulus (GO:0009595) | 2.61705172 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61137046 |
| 125 | heme transport (GO:0015886) | 2.60466474 |
| 126 | glucose catabolic process (GO:0006007) | 2.60055466 |
| 127 | regulation of cholesterol storage (GO:0010885) | 2.60027987 |
| 128 | positive regulation of tolerance induction (GO:0002645) | 2.59934184 |
| 129 | metanephric nephron tubule development (GO:0072234) | 2.58738561 |
| 130 | metanephric tubule development (GO:0072170) | 2.58738561 |
| 131 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.58399992 |
| 132 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.58399992 |
| 133 | L-serine metabolic process (GO:0006563) | 2.58333470 |
| 134 | cellular response to virus (GO:0098586) | 2.58186317 |
| 135 | embryonic placenta development (GO:0001892) | 2.57973843 |
| 136 | cortical cytoskeleton organization (GO:0030865) | 2.57932643 |
| 137 | short-chain fatty acid metabolic process (GO:0046459) | 2.55834757 |
| 138 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.55716646 |
| 139 | membrane tubulation (GO:0097320) | 2.55502699 |
| 140 | negative regulation of GTPase activity (GO:0034260) | 2.55135391 |
| 141 | negative regulation of GTP catabolic process (GO:0033125) | 2.55135391 |
| 142 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.55003698 |
| 143 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.55003698 |
| 144 | mature B cell differentiation (GO:0002335) | 2.54768497 |
| 145 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.54560750 |
| 146 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.53446143 |
| 147 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.53083931 |
| 148 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52960860 |
| 149 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.52633500 |
| 150 | acylglycerol metabolic process (GO:0006639) | 2.52539956 |
| 151 | regulation of leukocyte degranulation (GO:0043300) | 2.51703888 |
| 152 | cranial suture morphogenesis (GO:0060363) | 2.51508224 |
| 153 | regulation of type 2 immune response (GO:0002828) | 2.51190444 |
| 154 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.50709775 |
| 155 | glycerolipid catabolic process (GO:0046503) | 2.50365778 |
| 156 | NIK/NF-kappaB signaling (GO:0038061) | 2.50253137 |
| 157 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47947294 |
| 158 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.46165701 |
| 159 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45880696 |
| 160 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45506418 |
| 161 | response to host (GO:0075136) | 2.45506418 |
| 162 | response to host defenses (GO:0052200) | 2.45506418 |
| 163 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45278032 |
| 164 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.45132464 |
| 165 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43378653 |
| 166 | regulation of T cell tolerance induction (GO:0002664) | 2.42210113 |
| 167 | negative regulation of T cell mediated immunity (GO:0002710) | 2.42000447 |
| 168 | regulation of necroptotic process (GO:0060544) | 2.40894128 |
| 169 | myeloid dendritic cell differentiation (GO:0043011) | 2.40335931 |
| 170 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40224608 |
| 171 | response to host immune response (GO:0052572) | 2.40224608 |
| 172 | embryonic process involved in female pregnancy (GO:0060136) | 2.39854540 |
| 173 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.38272940 |
| 174 | defense response to protozoan (GO:0042832) | 2.37323117 |
| 175 | leukocyte aggregation (GO:0070486) | 2.36014981 |
| 176 | positive thymic T cell selection (GO:0045059) | 2.35999761 |
| 177 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.35435097 |
| 178 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.34341095 |
| 179 | regulation of early endosome to late endosome transport (GO:2000641) | 2.33619227 |
| 180 | T cell migration (GO:0072678) | 2.33064220 |
| 181 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.32849790 |
| 182 | positive regulation of type 2 immune response (GO:0002830) | 2.32619179 |
| 183 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31250824 |
| 184 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.30377347 |
| 185 | regulation of podosome assembly (GO:0071801) | 2.29591255 |
| 186 | regulation of mast cell degranulation (GO:0043304) | 2.28119519 |
| 187 | amyloid precursor protein catabolic process (GO:0042987) | 2.26899338 |
| 188 | immunoglobulin mediated immune response (GO:0016064) | 2.26696686 |
| 189 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.26503513 |
| 190 | apoptotic cell clearance (GO:0043277) | 2.25377855 |
| 191 | skin morphogenesis (GO:0043589) | 2.24715782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.54838884 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.89695986 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00666718 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67136151 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66016534 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48786054 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32817817 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30695984 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29531330 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28064956 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26290771 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.21298253 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19872179 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17753205 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15166996 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.15074416 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05883364 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05528404 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04754703 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04556065 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00187136 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95009321 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.92176594 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88819993 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87239572 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86731495 |
| 27 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.85800827 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85562955 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81482747 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78413937 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73420344 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68857518 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68034417 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66967778 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66684547 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65315866 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59520670 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57909817 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54951145 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52889173 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52496106 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52352260 |
| 43 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52172006 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.51496998 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51197230 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51073334 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50173353 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49353090 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46668338 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46312984 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41272824 |
| 52 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39383086 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39362445 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38409161 |
| 55 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.37947718 |
| 56 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.37947718 |
| 57 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.37947718 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37796583 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.36162229 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34303844 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34076895 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33827914 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33337826 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33253486 |
| 65 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.33183615 |
| 66 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.32961124 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31137532 |
| 68 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29996657 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29958610 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29413863 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28689210 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28198214 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27464208 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.26227244 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25714497 |
| 76 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23758867 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22801935 |
| 78 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.22801096 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22453973 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22293746 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21737705 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21112604 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18628971 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18248613 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16600014 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16551419 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.16368241 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16166563 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15826229 |
| 90 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15811469 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15781150 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14861317 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14735642 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13948916 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13898542 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13556618 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13202123 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12754208 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12167773 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12161078 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11946111 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11637384 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11579463 |
| 104 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.09208596 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08018980 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 1.07988507 |
| 107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07964842 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 1.07819561 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07453236 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06732338 |
| 111 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06214140 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05860286 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05673293 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05443588 |
| 115 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04242348 |
| 116 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04089038 |
| 117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03808614 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 1.03538997 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02529452 |
| 120 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02400976 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01954477 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01952651 |
| 123 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01642558 |
| 124 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.01588089 |
| 125 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01280927 |
| 126 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00808770 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00525102 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00486102 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00119177 |
| 130 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99167312 |
| 131 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99152885 |
| 132 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98416132 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98394002 |
| 134 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98386431 |
| 135 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98357415 |
| 136 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97612729 |
| 137 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97552767 |
| 138 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97449740 |
| 139 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97435223 |
| 140 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96727805 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96688986 |
| 142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96670731 |
| 143 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95897099 |
| 144 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92423789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 3.47760081 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.29235020 |
| 3 | MP0003436_decreased_susceptibility_to | 3.03570624 |
| 4 | MP0005451_abnormal_body_composition | 3.01785180 |
| 5 | MP0001348_abnormal_lacrimal_gland | 2.68248998 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.63209771 |
| 7 | MP0001958_emphysema | 2.57692253 |
| 8 | MP0005623_abnormal_meninges_morphology | 2.48379468 |
| 9 | MP0008260_abnormal_autophagy | 2.47226622 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.45584895 |
| 11 | MP0000537_abnormal_urethra_morphology | 2.45017706 |
| 12 | MP0009840_abnormal_foam_cell | 2.44214878 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.37865794 |
| 14 | MP0003690_abnormal_glial_cell | 2.28906310 |
| 15 | MP0003303_peritoneal_inflammation | 2.28422643 |
| 16 | MP0000920_abnormal_myelination | 2.20266121 |
| 17 | MP0003123_paternal_imprinting | 2.18899809 |
| 18 | MP0004782_abnormal_surfactant_physiolog | 2.17940340 |
| 19 | MP0003045_fibrosis | 2.16259337 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.08924807 |
| 21 | MP0003329_amyloid_beta_deposits | 2.06747388 |
| 22 | MP0002419_abnormal_innate_immunity | 2.06467864 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.00274412 |
| 24 | MP0000685_abnormal_immune_system | 1.99737320 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.96075459 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.92213233 |
| 27 | MP0004272_abnormal_basement_membrane | 1.87063888 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.82504444 |
| 29 | MP0004947_skin_inflammation | 1.82152911 |
| 30 | MP0000858_altered_metastatic_potential | 1.80429629 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.77743729 |
| 32 | MP0003279_aneurysm | 1.77713134 |
| 33 | MP0003252_abnormal_bile_duct | 1.75406509 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.75095140 |
| 35 | MP0004130_abnormal_muscle_cell | 1.74552850 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.74280234 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.72251020 |
| 38 | MP0009785_altered_susceptibility_to | 1.70351367 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.67215534 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.65723254 |
| 41 | MP0005360_urolithiasis | 1.64874826 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.64702278 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.63949505 |
| 44 | MP0000604_amyloidosis | 1.63139038 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.57747795 |
| 46 | MP0001881_abnormal_mammary_gland | 1.57499857 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.57177899 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.56485683 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.54996644 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.54950971 |
| 51 | MP0001800_abnormal_humoral_immune | 1.54596340 |
| 52 | MP0002723_abnormal_immune_serum | 1.51335292 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.49224847 |
| 54 | MP0004858_abnormal_nervous_system | 1.47271095 |
| 55 | MP0001819_abnormal_immune_cell | 1.42271526 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.42233324 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.42148388 |
| 58 | MP0005670_abnormal_white_adipose | 1.41293677 |
| 59 | MP0002405_respiratory_system_inflammati | 1.38965666 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35515343 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.35346106 |
| 62 | MP0003075_altered_response_to | 1.34999987 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.34177123 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.33725060 |
| 65 | MP0001849_ear_inflammation | 1.32931156 |
| 66 | MP0005388_respiratory_system_phenotype | 1.28156214 |
| 67 | MP0002133_abnormal_respiratory_system | 1.28156214 |
| 68 | MP0000747_muscle_weakness | 1.27086306 |
| 69 | MP0009278_abnormal_bone_marrow | 1.25469169 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.23686664 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.22465667 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.20865624 |
| 73 | MP0001835_abnormal_antigen_presentation | 1.19655778 |
| 74 | MP0005332_abnormal_amino_acid | 1.19606305 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.19428378 |
| 76 | MP0002398_abnormal_bone_marrow | 1.18342085 |
| 77 | MP0009764_decreased_sensitivity_to | 1.18290294 |
| 78 | MP0001177_atelectasis | 1.18058268 |
| 79 | MP0005330_cardiomyopathy | 1.17358832 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 1.17100229 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.16203652 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.16005598 |
| 83 | MP0005671_abnormal_response_to | 1.15332157 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 1.14712237 |
| 85 | MP0005023_abnormal_wound_healing | 1.13851824 |
| 86 | MP0001851_eye_inflammation | 1.13320619 |
| 87 | MP0004510_myositis | 1.13070085 |
| 88 | MP0001915_intracranial_hemorrhage | 1.13010234 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 1.11415652 |
| 90 | MP0001545_abnormal_hematopoietic_system | 1.11415652 |
| 91 | MP0001346_abnormal_lacrimal_gland | 1.11188631 |
| 92 | MP0000716_abnormal_immune_system | 1.11113934 |
| 93 | MP0000609_abnormal_liver_physiology | 1.10625718 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 1.10409651 |
| 95 | MP0005409_darkened_coat_color | 1.10181435 |
| 96 | MP0001845_abnormal_inflammatory_respons | 1.09533415 |
| 97 | MP0008469_abnormal_protein_level | 1.08477504 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 1.08121617 |
| 99 | MP0002971_abnormal_brown_adipose | 1.07831912 |
| 100 | MP0000343_altered_response_to | 1.07736840 |
| 101 | MP0005257_abnormal_intraocular_pressure | 1.07139297 |
| 102 | MP0004233_abnormal_muscle_weight | 1.06058427 |
| 103 | MP0003632_abnormal_nervous_system | 1.04553576 |
| 104 | MP0000733_abnormal_muscle_development | 1.04050710 |
| 105 | MP0002254_reproductive_system_inflammat | 1.03448447 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01118325 |
| 107 | MP0003828_pulmonary_edema | 1.00897196 |
| 108 | MP0004142_abnormal_muscle_tone | 1.00732699 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.98979655 |
| 110 | MP0002722_abnormal_immune_system | 0.97678149 |
| 111 | MP0001666_abnormal_nutrient_absorption | 0.97661955 |
| 112 | MP0001853_heart_inflammation | 0.97514581 |
| 113 | MP0002269_muscular_atrophy | 0.97354721 |
| 114 | MP0005164_abnormal_response_to | 0.96969091 |
| 115 | MP0000249_abnormal_blood_vessel | 0.96695822 |
| 116 | MP0004883_abnormal_blood_vessel | 0.96011385 |
| 117 | MP0002168_other_aberrant_phenotype | 0.94670346 |
| 118 | MP0005365_abnormal_bile_salt | 0.94017428 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.93253403 |
| 120 | MP0002429_abnormal_blood_cell | 0.92642639 |
| 121 | MP0002928_abnormal_bile_duct | 0.91147945 |
| 122 | MP0000689_abnormal_spleen_morphology | 0.90961201 |
| 123 | MP0005390_skeleton_phenotype | 0.90252513 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.88892199 |
| 125 | MP0003091_abnormal_cell_migration | 0.88548274 |
| 126 | MP0003724_increased_susceptibility_to | 0.87521692 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.86060088 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.85638978 |
| 129 | MP0008874_decreased_physiological_sensi | 0.84872761 |
| 130 | MP0005621_abnormal_cell_physiology | 0.84798187 |
| 131 | MP0000751_myopathy | 0.83553760 |
| 132 | MP0004885_abnormal_endolymph | 0.83545603 |
| 133 | MP0001542_abnormal_bone_strength | 0.82323912 |
| 134 | MP0006054_spinal_hemorrhage | 0.81704367 |
| 135 | MP0009763_increased_sensitivity_to | 0.78167658 |
| 136 | MP0003448_altered_tumor_morphology | 0.77660530 |
| 137 | MP0008004_abnormal_stomach_pH | 0.75425091 |
| 138 | MP0000383_abnormal_hair_follicle | 0.73704671 |
| 139 | MP0003634_abnormal_glial_cell | 0.73633072 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.72846551 |
| 141 | MP0002970_abnormal_white_adipose | 0.70074312 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.69152936 |
| 143 | MP0003631_nervous_system_phenotype | 0.68835644 |
| 144 | MP0003633_abnormal_nervous_system | 0.68319802 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.67241537 |
| 146 | MP0005387_immune_system_phenotype | 0.67000425 |
| 147 | MP0001790_abnormal_immune_system | 0.67000425 |
| 148 | MP0005025_abnormal_response_to | 0.66676376 |
| 149 | MP0008770_decreased_survivor_rate | 0.66061432 |
| 150 | MP0000598_abnormal_liver_morphology | 0.65488234 |
| 151 | MP0001614_abnormal_blood_vessel | 0.63993859 |
| 152 | MP0008873_increased_physiological_sensi | 0.63759737 |
| 153 | MP0004147_increased_porphyrin_level | 0.63513340 |
| 154 | MP0006082_CNS_inflammation | 0.60820175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 5.90431941 |
| 2 | Interstitial pulmonary disease (HP:0006530) | 5.10481483 |
| 3 | Scanning speech (HP:0002168) | 4.08888360 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.79840085 |
| 5 | Ragged-red muscle fibers (HP:0003200) | 3.48911293 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.46829202 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.32947586 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 3.32632775 |
| 9 | Progressive muscle weakness (HP:0003323) | 3.24114091 |
| 10 | Broad metatarsal (HP:0001783) | 3.23239398 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.21690157 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.21641037 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.17258382 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.12474242 |
| 15 | Overriding aorta (HP:0002623) | 3.10626446 |
| 16 | Subacute progressive viral hepatitis (HP:0006572) | 3.04767141 |
| 17 | Abnormality of macrophages (HP:0004311) | 2.93297224 |
| 18 | Ulnar bowing (HP:0003031) | 2.93073350 |
| 19 | Loss of speech (HP:0002371) | 2.91988841 |
| 20 | Achilles tendon contracture (HP:0001771) | 2.81687900 |
| 21 | Abnormality of the Achilles tendon (HP:0005109) | 2.79131129 |
| 22 | Spastic paraparesis (HP:0002313) | 2.77262513 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75906767 |
| 24 | Hemiplegia (HP:0002301) | 2.74033608 |
| 25 | Shallow orbits (HP:0000586) | 2.71973652 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.70917408 |
| 27 | Myositis (HP:0100614) | 2.67549336 |
| 28 | Turricephaly (HP:0000262) | 2.66802004 |
| 29 | Type 1 muscle fiber predominance (HP:0003803) | 2.64142843 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.62659647 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 2.61184302 |
| 32 | Nasal polyposis (HP:0100582) | 2.60107770 |
| 33 | Tachypnea (HP:0002789) | 2.57683075 |
| 34 | Xanthomatosis (HP:0000991) | 2.57297568 |
| 35 | Orchitis (HP:0100796) | 2.55791884 |
| 36 | Vertebral compression fractures (HP:0002953) | 2.53145105 |
| 37 | Delayed CNS myelination (HP:0002188) | 2.52348760 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.52264260 |
| 39 | Increased serum ferritin (HP:0003281) | 2.50346481 |
| 40 | Bowel diverticulosis (HP:0005222) | 2.46391359 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.46379480 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.42995452 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42302565 |
| 44 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.38895870 |
| 45 | Amyloidosis (HP:0011034) | 2.38258244 |
| 46 | Coronal craniosynostosis (HP:0004440) | 2.34065566 |
| 47 | Infantile muscular hypotonia (HP:0008947) | 2.33450937 |
| 48 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.31925890 |
| 49 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.31925890 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.31378308 |
| 51 | Increased connective tissue (HP:0009025) | 2.31272205 |
| 52 | Optic neuritis (HP:0100653) | 2.30889191 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.30889191 |
| 54 | Slow saccadic eye movements (HP:0000514) | 2.30660028 |
| 55 | Cellulitis (HP:0100658) | 2.29250733 |
| 56 | Sensory axonal neuropathy (HP:0003390) | 2.28810145 |
| 57 | Purpura (HP:0000979) | 2.28460131 |
| 58 | Gingivitis (HP:0000230) | 2.26072138 |
| 59 | Muscle fiber inclusion bodies (HP:0100299) | 2.25562269 |
| 60 | Glomerulosclerosis (HP:0000096) | 2.24777730 |
| 61 | Nemaline bodies (HP:0003798) | 2.24661437 |
| 62 | Partial duplication of thumb phalanx (HP:0009944) | 2.23858836 |
| 63 | Premature skin wrinkling (HP:0100678) | 2.21034541 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.20203517 |
| 65 | Abnormality of the periventricular white matter (HP:0002518) | 2.19505735 |
| 66 | Bowed forearm bones (HP:0003956) | 2.18591431 |
| 67 | Bowing of the arm (HP:0006488) | 2.18591431 |
| 68 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.17651320 |
| 69 | Plagiocephaly (HP:0001357) | 2.15985588 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.14373868 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13907974 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.13907974 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.13649664 |
| 74 | Abnormality of the salivary glands (HP:0010286) | 2.13513595 |
| 75 | Myocardial infarction (HP:0001658) | 2.13446065 |
| 76 | Partial duplication of the phalanx of hand (HP:0009999) | 2.13338178 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 2.12071539 |
| 78 | Peritonitis (HP:0002586) | 2.11876248 |
| 79 | Micronodular cirrhosis (HP:0001413) | 2.11128343 |
| 80 | Difficulty running (HP:0009046) | 2.10700963 |
| 81 | Thoracic kyphosis (HP:0002942) | 2.10559065 |
| 82 | Stomach cancer (HP:0012126) | 2.10052678 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.09732739 |
| 84 | Stridor (HP:0010307) | 2.09673272 |
| 85 | Mitral valve prolapse (HP:0001634) | 2.09174167 |
| 86 | Cervical subluxation (HP:0003308) | 2.08411028 |
| 87 | Intention tremor (HP:0002080) | 2.08242798 |
| 88 | Polygenic inheritance (HP:0010982) | 2.08236886 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.08114275 |
| 90 | Resting tremor (HP:0002322) | 2.07161038 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.05949520 |
| 92 | Spondylolisthesis (HP:0003302) | 2.05654653 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04156128 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04156128 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04156128 |
| 96 | Paraparesis (HP:0002385) | 2.03033584 |
| 97 | Aneurysm (HP:0002617) | 2.02906397 |
| 98 | Macroorchidism (HP:0000053) | 2.02188878 |
| 99 | Postural instability (HP:0002172) | 2.01084176 |
| 100 | Hepatocellular carcinoma (HP:0001402) | 1.99435345 |
| 101 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98592549 |
| 102 | Spastic gait (HP:0002064) | 1.97918279 |
| 103 | Hyperacusis (HP:0010780) | 1.97877376 |
| 104 | Abnormality of complement system (HP:0005339) | 1.96362640 |
| 105 | Muscle fiber splitting (HP:0003555) | 1.96183915 |
| 106 | Genu recurvatum (HP:0002816) | 1.95337611 |
| 107 | Recurrent viral infections (HP:0004429) | 1.95026785 |
| 108 | Intrahepatic cholestasis (HP:0001406) | 1.94227580 |
| 109 | Protrusio acetabuli (HP:0003179) | 1.94227545 |
| 110 | Dilatation of the ascending aorta (HP:0005111) | 1.94216150 |
| 111 | Thin bony cortex (HP:0002753) | 1.94081609 |
| 112 | Gingival bleeding (HP:0000225) | 1.94024299 |
| 113 | Spastic diplegia (HP:0001264) | 1.93976838 |
| 114 | Cerebral hypomyelination (HP:0006808) | 1.93917499 |
| 115 | Chronic otitis media (HP:0000389) | 1.93432176 |
| 116 | Hypokinesia (HP:0002375) | 1.92876812 |
| 117 | Ulnar deviation of the wrist (HP:0003049) | 1.91475947 |
| 118 | Termporal pattern (HP:0011008) | 1.91196691 |
| 119 | Insidious onset (HP:0003587) | 1.91196691 |
| 120 | Rapidly progressive (HP:0003678) | 1.90875551 |
| 121 | Gastrointestinal infarctions (HP:0005244) | 1.90381791 |
| 122 | Myoglobinuria (HP:0002913) | 1.90120462 |
| 123 | Polycythemia (HP:0001901) | 1.90032429 |
| 124 | Premature rupture of membranes (HP:0001788) | 1.89795259 |
| 125 | Axonal loss (HP:0003447) | 1.89710005 |
| 126 | Recurrent skin infections (HP:0001581) | 1.89099533 |
| 127 | Respiratory distress (HP:0002098) | 1.88665473 |
| 128 | Abnormality of the thoracic spine (HP:0100711) | 1.88238869 |
| 129 | Spinal rigidity (HP:0003306) | 1.88061887 |
| 130 | Epidermoid cyst (HP:0200040) | 1.87408167 |
| 131 | Arnold-Chiari malformation (HP:0002308) | 1.87192674 |
| 132 | Hemorrhage of the eye (HP:0011885) | 1.85639978 |
| 133 | Clonus (HP:0002169) | 1.85615560 |
| 134 | Anteriorly placed anus (HP:0001545) | 1.84614893 |
| 135 | Blue sclerae (HP:0000592) | 1.84222592 |
| 136 | Vacuolated lymphocytes (HP:0001922) | 1.83816845 |
| 137 | Disproportionate tall stature (HP:0001519) | 1.82315111 |
| 138 | Spinal cord lesions (HP:0100561) | 1.82181172 |
| 139 | Syringomyelia (HP:0003396) | 1.82181172 |
| 140 | Gout (HP:0001997) | 1.81704848 |
| 141 | Complement deficiency (HP:0004431) | 1.80790452 |
| 142 | Viral hepatitis (HP:0006562) | 1.80226631 |
| 143 | Clumsiness (HP:0002312) | 1.80078279 |
| 144 | Slender build (HP:0001533) | 1.79492208 |
| 145 | Short nail (HP:0001799) | 1.78032762 |
| 146 | Flat acetabular roof (HP:0003180) | 1.78029025 |
| 147 | Abnormality of the peritoneum (HP:0002585) | 1.78026498 |
| 148 | Vascular tortuosity (HP:0004948) | 1.76320434 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.75120472 |
| 150 | Back pain (HP:0003418) | 1.75078357 |
| 151 | Arterial thrombosis (HP:0004420) | 1.74856475 |
| 152 | Abnormality of iron homeostasis (HP:0011031) | 1.74679205 |
| 153 | Megalencephaly (HP:0001355) | 1.74463038 |
| 154 | Atrophic scars (HP:0001075) | 1.74305278 |
| 155 | Metaphyseal cupping (HP:0003021) | 1.74264881 |
| 156 | Insomnia (HP:0100785) | 1.73901579 |
| 157 | Hyperglycinuria (HP:0003108) | 1.73514968 |
| 158 | Ankle contracture (HP:0006466) | 1.73272778 |
| 159 | Osteolytic defects of the hand bones (HP:0009699) | 1.72090923 |
| 160 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72090923 |
| 161 | Buphthalmos (HP:0000557) | 1.71769512 |
| 162 | Annular pancreas (HP:0001734) | 1.71583229 |
| 163 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71435107 |
| 164 | Obstructive lung disease (HP:0006536) | 1.70914705 |
| 165 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70914705 |
| 166 | Meningitis (HP:0001287) | 1.70115457 |
| 167 | Nuclear cataract (HP:0100018) | 1.69775647 |
| 168 | Glomerulonephritis (HP:0000099) | 1.69462452 |
| 169 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69352504 |
| 170 | Mucopolysacchariduria (HP:0008155) | 1.69352504 |
| 171 | Stomatitis (HP:0010280) | 1.69123320 |
| 172 | Keratoconjunctivitis sicca (HP:0001097) | 1.67262406 |
| 173 | T lymphocytopenia (HP:0005403) | 1.66760963 |
| 174 | Difficulty climbing stairs (HP:0003551) | 1.66731637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.89452180 |
| 2 | TRIB3 | 3.36637761 |
| 3 | BCKDK | 3.10594836 |
| 4 | SMG1 | 2.97348734 |
| 5 | ERN1 | 2.93371886 |
| 6 | MAP2K3 | 2.72258194 |
| 7 | ICK | 2.65198437 |
| 8 | EPHB1 | 2.52572005 |
| 9 | STK39 | 2.38274723 |
| 10 | LRRK2 | 2.15584169 |
| 11 | SIK1 | 2.11808283 |
| 12 | MATK | 2.09339091 |
| 13 | MAP3K10 | 1.97997750 |
| 14 | MAP3K14 | 1.95941049 |
| 15 | RIPK4 | 1.95651772 |
| 16 | BLK | 1.93686762 |
| 17 | CDK12 | 1.91677415 |
| 18 | MAP3K9 | 1.88968797 |
| 19 | BMX | 1.82614278 |
| 20 | FGFR2 | 1.75542409 |
| 21 | TIE1 | 1.74971080 |
| 22 | PRKCH | 1.73324100 |
| 23 | MET | 1.72110877 |
| 24 | CAMK1D | 1.69248100 |
| 25 | TAOK2 | 1.64257900 |
| 26 | NTRK1 | 1.63413404 |
| 27 | TYRO3 | 1.60478972 |
| 28 | CAMK1G | 1.51489885 |
| 29 | PKN2 | 1.51402014 |
| 30 | IRAK4 | 1.49966477 |
| 31 | RIPK1 | 1.44994753 |
| 32 | ZAK | 1.41906822 |
| 33 | MAP3K3 | 1.39871172 |
| 34 | SCYL2 | 1.38986673 |
| 35 | KSR2 | 1.38626964 |
| 36 | MAP3K11 | 1.34304802 |
| 37 | DDR2 | 1.32176097 |
| 38 | ALK | 1.29789687 |
| 39 | CSK | 1.28009368 |
| 40 | CDK19 | 1.27713127 |
| 41 | TAOK1 | 1.22121090 |
| 42 | MOS | 1.20789348 |
| 43 | CDC42BPA | 1.17480970 |
| 44 | PRKD2 | 1.16958083 |
| 45 | MAP4K1 | 1.16787323 |
| 46 | FES | 1.14656954 |
| 47 | MAP3K6 | 1.14012690 |
| 48 | MAP3K8 | 1.14003565 |
| 49 | STK10 | 1.13057601 |
| 50 | MAP3K1 | 1.12092873 |
| 51 | TTN | 1.10482489 |
| 52 | HIPK2 | 1.08479870 |
| 53 | CSF1R | 1.08292261 |
| 54 | NEK9 | 1.08167170 |
| 55 | WNK1 | 1.07739613 |
| 56 | OXSR1 | 1.06202555 |
| 57 | TGFBR2 | 1.04255455 |
| 58 | PTK6 | 1.01247368 |
| 59 | MAPK12 | 0.98787998 |
| 60 | PAK4 | 0.97434115 |
| 61 | IKBKE | 0.97177728 |
| 62 | MST1R | 0.95782136 |
| 63 | PAK2 | 0.94944202 |
| 64 | EPHA2 | 0.92348524 |
| 65 | GRK6 | 0.92319912 |
| 66 | PDPK1 | 0.91178469 |
| 67 | MAPK7 | 0.91124309 |
| 68 | PRKD1 | 0.88178994 |
| 69 | FGR | 0.85752206 |
| 70 | ABL2 | 0.85634491 |
| 71 | TYK2 | 0.85185528 |
| 72 | DAPK2 | 0.83156686 |
| 73 | ILK | 0.82718907 |
| 74 | ROCK2 | 0.82284539 |
| 75 | ARAF | 0.81625180 |
| 76 | LMTK2 | 0.81258538 |
| 77 | GSK3A | 0.80396396 |
| 78 | LATS2 | 0.79632331 |
| 79 | PKN1 | 0.78732368 |
| 80 | SIK2 | 0.75570700 |
| 81 | GRK7 | 0.74932851 |
| 82 | FGFR4 | 0.73998465 |
| 83 | DAPK3 | 0.72796230 |
| 84 | TBK1 | 0.71478527 |
| 85 | JAK3 | 0.70677893 |
| 86 | PDGFRA | 0.70676134 |
| 87 | IRAK3 | 0.69803891 |
| 88 | JAK2 | 0.68917113 |
| 89 | TNK2 | 0.67721950 |
| 90 | RPS6KA2 | 0.67378878 |
| 91 | EEF2K | 0.67105510 |
| 92 | DYRK1B | 0.66024035 |
| 93 | PIK3CG | 0.65850945 |
| 94 | ZAP70 | 0.64332481 |
| 95 | MAP3K13 | 0.63340642 |
| 96 | RPS6KL1 | 0.62928109 |
| 97 | RPS6KC1 | 0.62928109 |
| 98 | CDK9 | 0.62478401 |
| 99 | HCK | 0.61784286 |
| 100 | FGFR3 | 0.60877708 |
| 101 | TGFBR1 | 0.59867086 |
| 102 | LCK | 0.59839566 |
| 103 | CDK4 | 0.58852657 |
| 104 | STK11 | 0.58331892 |
| 105 | CSNK1G1 | 0.58148483 |
| 106 | DMPK | 0.57786717 |
| 107 | MAP3K7 | 0.56545273 |
| 108 | TTK | 0.56161132 |
| 109 | PRKCQ | 0.55645514 |
| 110 | CSNK1G3 | 0.55563010 |
| 111 | STK24 | 0.53928811 |
| 112 | CLK1 | 0.53772180 |
| 113 | RET | 0.53600427 |
| 114 | OBSCN | 0.52597596 |
| 115 | UHMK1 | 0.51508194 |
| 116 | IRAK2 | 0.51137952 |
| 117 | CAMK2G | 0.50690486 |
| 118 | NME2 | 0.50633512 |
| 119 | SYK | 0.50456712 |
| 120 | PAK3 | 0.50149178 |
| 121 | MARK2 | 0.50020194 |
| 122 | LATS1 | 0.49537233 |
| 123 | PDK1 | 0.49149032 |
| 124 | JAK1 | 0.48916518 |
| 125 | MELK | 0.47447068 |
| 126 | CDK6 | 0.47316824 |
| 127 | MAP3K5 | 0.47052503 |
| 128 | MAPK11 | 0.46215122 |
| 129 | MAP2K2 | 0.45035366 |
| 130 | MAP2K4 | 0.44186312 |
| 131 | MTOR | 0.44117736 |
| 132 | LYN | 0.43798577 |
| 133 | CAMK1 | 0.43675968 |
| 134 | BTK | 0.43606111 |
| 135 | MAP3K2 | 0.42772541 |
| 136 | PDGFRB | 0.42766085 |
| 137 | INSR | 0.41792947 |
| 138 | ABL1 | 0.40851312 |
| 139 | RAF1 | 0.39971351 |
| 140 | WNK4 | 0.39621082 |
| 141 | PRKAA2 | 0.39306675 |
| 142 | STK38 | 0.39252820 |
| 143 | KIT | 0.38463757 |
| 144 | IRAK1 | 0.38434593 |
| 145 | CDK14 | 0.38332096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.09662606 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.63328337 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.60861411 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.89199688 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72334997 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71946143 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.60236818 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.48280407 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35707429 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27379131 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16775785 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12285529 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.06475657 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.04830153 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02493918 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01816731 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98140882 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82530639 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80707014 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.77419955 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.76994235 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63313104 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58689773 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48421945 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48136345 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48108775 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.46738238 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45501740 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.45154899 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43999367 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42134903 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41323268 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.41091387 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41079505 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.39913355 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.35566611 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32920938 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31864858 |
| 39 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.29573870 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29518853 |
| 41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.28169538 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.27160210 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24082002 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22707910 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22453140 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22129386 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19299713 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17902549 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.17519810 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17163024 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16657883 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.09392223 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08321790 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.07784399 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.07295241 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.07188456 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06833987 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06655628 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04748788 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 1.04573869 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03620305 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 1.03326741 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03044154 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02911315 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01254369 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00381050 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98690023 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.98454253 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97430088 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96501804 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95053868 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94375640 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92188468 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.90326821 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90168927 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89458847 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89135328 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88275628 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88094458 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87806017 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87783371 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87451987 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86894896 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85728257 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.84970635 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.83691979 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83341530 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82475425 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81997750 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.81648043 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.80214640 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78240416 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77442794 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.77029261 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76355373 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.76343193 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76246939 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76018789 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.75331425 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74627983 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71564740 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70881157 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69709500 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69558564 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68651696 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.68056903 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67873237 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.66793239 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66755036 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66149411 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.64592336 |
| 112 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64448473 |
| 113 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63279693 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62574700 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62296490 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.61971878 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61872361 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61326620 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.60224032 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60188603 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60126311 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59625011 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59531912 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59049961 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.58973578 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58586588 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58422134 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.58029345 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56694441 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55436551 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55381283 |
| 132 | Melanogenesis_Homo sapiens_hsa04916 | 0.53991641 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52116172 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51282964 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51173650 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49576145 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49502093 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48867115 |
| 139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47703783 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46530433 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.46359220 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44053718 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42466438 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.40967564 |
| 145 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40921478 |
| 146 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40524259 |
| 147 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39656159 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39648430 |
| 149 | Gap junction_Homo sapiens_hsa04540 | 0.38386718 |
| 150 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37797881 |
| 151 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37214984 |
| 152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37006345 |
| 153 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35058576 |
| 154 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34868166 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34691735 |
| 156 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33950128 |
| 157 | Salivary secretion_Homo sapiens_hsa04970 | 0.33766273 |
| 158 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33356958 |
| 159 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29019027 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.29008917 |
| 161 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28599715 |
| 162 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28512502 |

